PHP
Speed Up Your PHP HTTP Guzzle Requests With Concurrency
Guzzle can do this out of the box! This technique is also used to power some of the checks in Oh Dear. Read more
Guzzle can do this out of the box! This technique is also used to power some of the checks in Oh Dear. Read more
The Apple Watch supports flipping watch orientation. | Photo by Victoria Song / The Verge When it comes to watches, southpaws often get the short end of the stick. Unless lefties buy a destro watch, Read more…
EUR/USD Price May Fall towards This Level A trust issue with Mr Putin Waiting for Mr Powell’s press conference EUR/USD critical levels to monitor The EU held an emergency meeting yesterday to discuss plans to Read more…
Solid, if cautious, near-term outlooks from Microsoft and Google are giving stocks a boost ahead of today’s crucial Fed rate decision. U.S. equity futures bumped higher Wednesday, powered by a spate of better-than-expected big tech Read more…
On Wednesday, 27th of July, at 18:00 GMT, the Fed will release its monetary policy decision, including the interest rate and the QE programme. The news is expected to cause a surge of volatility in Read more…
AUDNZD broke resistance level 1.1100 Likely to rise to resistance level 1.1165 AUDNZD recently broke the key resistance level 1.1100 (which has been steadily reversing the pair from the end of June). The breakout of Read more…
Silver reversed from support level 18.30 Likely to rise to resistance level 18.90 Silver earlier reversed up from the pivotal support level 18.30 (which has been steadily reversing the price from the end of June). Read more…
The US Dollar started a fresh increase after it tested the 135.60 zone against the Japanese Yen. The USD/JPY pair traded above the 136.20 level to move into a positive zone. The pair even moved Read more…
“We made important progress across key programs in the second quarter and are building momentum in our turnaround,” said CEO Dave Calhoun. Updated at 7:45 am EST Boeing (BA) – Get The Boeing Company Report posted Read more…
Solid cancer and blood clot treatment sales, as well as a smaller-than-forecast decline for Revlimid, helped deliver a top and bottom line beat for drugmaker Bristol Myers. Bristol Myers Squibb (BMY) – Get Bristol-Myers Squibb Read more…